Inositol for PCOS, Fertility & Anxiety: The Complete Evidence Guide
What Is Inositol?
Inositol is a naturally occurring carbocyclic sugar that functions as a second messenger in cellular signalling β it is part of the phosphatidylinositol signalling pathway that cells use to respond to insulin, FSH, TSH, and many other hormones. It is often grouped with the B-vitamin family (sometimes called vitamin B8) though it is technically not a vitamin since the body can synthesise it from glucose.
The two forms most relevant to supplementation are: - Myo-inositol (MI): The most abundant form in the body and in food; the dominant form in the follicular fluid of the ovaries - D-chiro-inositol (DCI): Produced from myo-inositol by an insulin-dependent epimerase enzyme; involved in glycogen synthesis and androgen metabolism
Both forms serve as second messengers for insulin signalling, but in different tissues. In PCOS, the conversion of myo-inositol to D-chiro-inositol is impaired β leading to a relative deficiency of DCI where it is needed (muscle and liver) and potentially excess DCI in the ovaries.
---
Why PCOS and Inositol Are Closely Linked
Polycystic ovary syndrome affects approximately 1 in 10 women of reproductive age in the UK. It is characterised by a triad of features: hyperandrogenaemia (excess androgens), oligo/anovulation (irregular or absent ovulation), and polycystic ovarian morphology on ultrasound. Insulin resistance is present in 50β80% of women with PCOS regardless of BMI, and hyperinsulinaemia drives increased ovarian androgen production β worsening the hormonal disruption.
This is where inositol becomes relevant: both MI and DCI are insulin sensitisers that work at the cellular signalling level, independent of the systemic insulin-sensitising mechanisms of drugs like metformin.
---
The Clinical Evidence for PCOS
Insulin Sensitivity and Metabolic Markers
A 2011 study by Unfer et al. in Gynecological Endocrinology found that 4g myo-inositol + 400mcg folic acid daily for 12 weeks significantly reduced fasting insulin, HOMA-IR (insulin resistance index), and triglycerides in women with PCOS compared to folic acid alone.
A 2012 meta-analysis by Pundir et al. reviewed 7 RCTs and found consistent improvements in insulin sensitivity markers and a reduction in free androgen index (FAI) with myo-inositol supplementation.
Ovulation Restoration
This is the most compelling clinical outcome. Multiple RCTs have found that myo-inositol supplementation restores ovulation in anovulatory PCOS patients:
- Gerli et al. (2007): 25% of women had restored spontaneous ovulation with 4g MI/day over 16 weeks - Papaleo et al. (2009): Women undergoing ovulation induction with FSH required significantly lower FSH doses and had better egg quality with MI pre-treatment - A 2016 Cochrane-adjacent systematic review found MI alone or MI+DCI improved ovulation rates in anovulatory PCOS, with effect sizes comparable to low-dose metformin but with a superior side effect profile
The 40:1 Myo-inositol to D-Chiro-Inositol Ratio
Research by Nordio and Proietto (2012) and subsequent work established that the physiological plasma ratio of MI to DCI is approximately 40:1. Supplementing with pure DCI at high doses was found to actually worsen oocyte (egg) quality in some studies β a paradox explained by the fact that the ovary needs MI, not DCI, for FSH signalling.
Most clinical guidelines now recommend the 40:1 MI:DCI ratio for PCOS: typically 4,000mg myo-inositol + 100mg D-chiro-inositol per day. This is now the standard dose used in Italian and Spanish fertility protocols and is widely available in UK supplements.
---
Evidence for Anxiety
Inositol has a separate and interesting evidence base for anxiety, operating through a different mechanism: it is a precursor to the phosphatidylinositol second messenger system that mediates serotonin (5-HT2) and other receptor responses. Depleted inositol has been found in cerebrospinal fluid of depressed patients.
A 1995 double-blind RCT by Benjamin et al. in Journal of Clinical Psychiatry found 18g/day of inositol significantly reduced panic attack frequency compared to placebo in 21 patients with panic disorder. The dose required is much higher than for PCOS.
A 1997 trial found similar effects for obsessive-compulsive disorder at 18g/day. For generalised anxiety, the evidence is less robust.
Note: anxiety doses (12β18g/day) are much higher than PCOS doses (4g/day). At these doses, GI side effects (loose stools, nausea) become more common and usually limit long-term use.
---
Inositol in Pregnancy and Gestational Diabetes
One of the most promising emerging areas. A 2013 RCT by D'Anna et al. in Diabetes Care found that 4g myo-inositol daily during pregnancy significantly reduced the incidence of gestational diabetes in overweight women at risk (from 13.9% in placebo to 6.3% in myo-inositol group). Importantly, no adverse effects on mother or foetus were observed.
Inositol is being studied as a safe, non-pharmacological intervention for gestational diabetes prevention in high-risk pregnancies. While not yet standard-of-care in UK guidelines, it has a plausible mechanism and a strong safety signal during pregnancy.
---
Dosing Summary
| Purpose | Daily Dose | Form | |---|---|---| | PCOS (ovulation, metabolic) | 4,000mg MI + 100mg DCI | 40:1 ratio product | | Fertility support (IVF prep) | 4,000mg MI + 100mg DCI | As above, with 400mcg folic acid | | Anxiety/panic disorder | 12,000β18,000mg | Myo-inositol powder | | Gestational diabetes prevention | 4,000mg MI | Myo-inositol only |
Myo-inositol powder is the most economical form for high-dose use. It is tasteless and dissolves well in water. Capsules are convenient at PCOS doses.
---
Who Benefits Most?
- Women with PCOS, particularly those with anovulation, insulin resistance, or elevated androgens - Women preparing for IVF who want to optimise egg quality - Women with PCOS who are trying to conceive naturally - Overweight women at risk of gestational diabetes - People with panic disorder or OCD seeking adjunctive non-pharmaceutical support
---
Safety Profile
Inositol is exceptionally well-tolerated. It is naturally present in foods (particularly beans, wholegrains, and citrus) at gram-level amounts. At PCOS doses (4g/day), side effects are rare. At anxiety doses (12β18g/day), mild GI effects (loose stools, nausea, bloating) occur in some people, usually resolving within 1β2 weeks.
No significant drug interactions have been identified. It is considered safe in pregnancy based on available evidence. There are no known contraindications for healthy adults.
For women with PCOS navigating a landscape of expensive and often poorly evidenced supplements, inositol β particularly the 40:1 MI:DCI combination β is one of the most evidence-backed, affordable, and safe options available.
β¨ Not sure which supplements are right for you?
Our 60-second quiz recommends a personalised stack based on your goals, diet and lifestyle. 8,400+ people found their stack this month β no email required.
Get weekly supplement insights
Join 12,000+ health-conscious readers. Plain-English science, no fluff, unsubscribe any time.
No spam. Unsubscribe any time.